MB

MPM BioImpact Portfolio holdings

AUM $577M
This Quarter Return
-24.96%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$373M
AUM Growth
+$373M
Cap. Flow
-$15.2M
Cap. Flow %
-4.07%
Top 10 Hldgs %
67.37%
Holding
38
New
5
Increased
4
Reduced
17
Closed
1

Top Buys

1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$5.9M
2
ARQT icon
Arcutis Biotherapeutics
ARQT
$4.98M
3
RLMD icon
Relmada Therapeutics
RLMD
$3.73M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
$2.63M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.54M

Top Sells

1
MEIP icon
MEI Pharma
MEIP
$33M
2
ITOS
iTeos Therapeutics
ITOS
$3.18M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
$372K
4
CYTK icon
Cytokinetics
CYTK
$295K
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
$288K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EPIX icon
26
ESSA Pharma
EPIX
$11.2M
$4.08M 1.1%
660,892
-7,796
-1% -$48.2K
EPZM
27
DELISTED
Epizyme, Inc
EPZM
$3.94M 1.06%
3,425,202
– –
RVMD icon
28
Revolution Medicines
RVMD
$7.43B
$3.73M 1%
146,041
– –
RLMD icon
29
Relmada Therapeutics
RLMD
$48.8M
$3.73M 1%
+138,000
New +$3.73M
ACAD icon
30
Acadia Pharmaceuticals
ACAD
$4.34B
$3.68M 0.99%
151,750
+26,750
+21% +$648K
AVDL
31
Avadel Pharmaceuticals
AVDL
$1.42B
$2.82M 0.76%
412,363
+37,037
+10% +$253K
PHAT icon
32
Phathom Pharmaceuticals
PHAT
$843M
$2.63M 0.71%
+193,326
New +$2.63M
KRTX
33
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.54M 0.68%
+20,000
New +$2.54M
NEO icon
34
NeoGenomics
NEO
$1.06B
$1.65M 0.44%
135,573
-4,849
-3% -$58.9K
INZY
35
DELISTED
Inozyme Pharma
INZY
$1.21M 0.32%
294,980
-7,635
-3% -$31.2K
TECX
36
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$855K 0.23%
647,918
– –
BDTX icon
37
Black Diamond Therapeutics
BDTX
$164M
$664K 0.18%
239,888
– –
MEIP icon
38
MEI Pharma
MEIP
$149M
– –
-12,350,971
Closed -$33M
1
2